title: Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer.
authors.affiliation: City of Hope Comprehensive Cancer Center, Duarte, California, USA. kreckamp@coh.org
authors.forename: Karen
authors.initials: K
authors.lastname: Reckamp
authors.forename: Barbara
authors.initials: B
authors.lastname: Gitlitz
authors.forename: Lin-Chi
authors.initials: LC
authors.lastname: Chen
authors.forename: Ravi
authors.initials: R
authors.lastname: Patel
authors.forename: Ginger
authors.initials: G
authors.lastname: Milne
authors.forename: Mary
authors.initials: M
authors.lastname: Syto
authors.forename: Deborah
authors.initials: D
authors.lastname: Jezior
authors.forename: Sara
authors.initials: S
authors.lastname: Zaknoen